MRCGP AKT → People at the end of life
People at the end of life accounts for roughly 1.5% of the MRCGP AKT blueprint. This bank has 13 items tagged to it.
Around 1.5% of the paper, per RCGP GP curriculum (2025). That weighting is why the DocPasser mock builder samples sections in proportion rather than shuffling everything into one pile — practising a flat distribution trains you for a paper that does not exist.
A 71-year-old man with lung cancer that has spread takes modified-release morphine 30 mg twice daily. His pain is controlled, but he asks for something for breakthrough pain. Which is the most appropriate breakthrough dose of immediate-release oral morphine?
The point: Breakthrough dose = one sixth of the total 24-hour morphine dose. If he needs three or more breakthrough doses a day, increase the regular dose. Always prescribe a laxative alongside strong opioids.
Source: NICE CG140: Palliative care for adults: strong opioids for pain relief NICE · tier 1, national regulator or guidance
A 66-year-old woman has advanced ovarian cancer. She takes modified-release morphine 20 mg twice daily for pain and has done so for three weeks. She feels full after a few mouthfuls and has hiccups. Sometimes she brings up a large amount of undigested food, and the nausea then eases. Her abdomen is soft with no colicky pain, and her bowels open normally. Her liver edge is felt 8 cm below the ribs. Her corrected calcium is 2.4 mmol/L (2.2 to 2.6). According to the BNF, which is the most appropriate antiemetic?
The point: Choose the antiemetic by the cause of the nausea, as the BNF palliative care guidance sets out. Slow stomach emptying: metoclopramide. Chemical causes such as opioids, high calcium or kidney failure: haloperidol. Raised intracranial pressure, vestibular causes or bowel obstruction: cyclizine. Do not give metoclopramide and cyclizine together because they oppose each other. Avoid metoclopramide if the bowel is completely blocked.
Source: BNF: Metoclopramide hydrochloride British National Formulary · tier 3, national formulary
A 77-year-old man with lung cancer that has spread is in the last days of life at home. He is breathless at rest and looks frightened. His oxygen saturation is 95% on air. The GP finds no sign of fluid on the lungs or a pleural effusion. He is drowsy and can no longer swallow tablets. He takes no regular opioid. His wife has opened the window and tried a handheld fan, with little effect. According to current national guidance, which is the most appropriate next step?
The point: In the last days of life, look for and treat reversible causes of breathlessness first, such as pulmonary oedema or a pleural effusion. Use non-drug measures like a fan. Do not start oxygen routinely. Offer it only if symptomatic hypoxaemia is known or suspected. NICE NG31 says consider an opioid or a benzodiazepine, or both. Start at the lowest effective dose and review at least daily.
Source: NICE NG31: Care of dying adults in the last days of life NICE · tier 1, national regulator or guidance
Cardiovascular health · Metabolic problems and endocrinology · Gastroenterology and nutrition · Children and young people · Mental health, alcohol and substance misuse · Women's health: gynaecology, pregnancy, contraception and breast · Respiratory health · Dermatology · Ear, nose and throat, speech and hearing · Musculoskeletal health · Neurology · Eyes and vision · Renal and urology · Men's health · Haematology · Allergy and clinical immunology · Infectious diseases, travel and sexual health · Therapeutics and safe prescribing · Organisation, management and administration · Evidence-based practice and data interpretation